Emtriva and Pain exacerbated - a phase IV clinical study of FDA data

Summary:

Pain exacerbated is reported as a side effect among people who take Emtriva (emtricitabine), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Truvada, and have Hiv infection.

The phase IV clinical study analyzes which people have Pain exacerbated when taking Emtriva. It is created by eHealthMe based on reports of 2,376 people who have side effects when taking Emtriva from the FDA, and is updated regularly.

What is Emtriva?

Emtriva has active ingredients of emtricitabine. eHealthMe is studying from 2,383 Emtriva users. Check the latest studies of Emtriva.

What is Pain exacerbated?

Pain exacerbated is found to be associated with 3,987 drugs and 3,019 conditions by eHealthMe. Check the latest studies of Pain exacerbated.

On Jul, 13, 2026

2,376 people reported to have side effects when taking Emtriva.
Among them, 419 people (17.63%) have Pain exacerbated.

Among these 419 people:

* Approximation only. Some reports may have incomplete information.

Do you take Emtriva and have Pain exacerbated?

- Check whether Pain exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emtriva:

Emtriva (2,383 reports)

Pain exacerbated treatments and more:

Pain exacerbated (1,595 reports)

How severe was Pain exacerbated and when was it recovered:

Pain exacerbated in Emtriva

Expand to all the drugs that have ingredients of emtricitabine:

Pain exacerbated and drugs with ingredients of emtricitabine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pain exacerbated:

Pain exacerbated (3,987 drugs)

Browse all the conditions that are associated with Pain exacerbated:

Pain exacerbated (3,019 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on emtricitabine (the active ingredients of Emtriva) and Emtriva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.